FIELD: medicine; pharmaceutics.
SUBSTANCE: present invention relates to a compound of formula:
,
in which R1, R3, R5 are absent, R2, R4 independently represent 
and R6 independently represents 
or
which can be used for treating cancer, as well as a pharmaceutical composition containing same.
EFFECT: compositions and methods for treating cancer are disclosed.
5 cl, 7 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS OF TREATMENT OF IRRITABLE BOWEL SYNDROME | 2017 |
|
RU2751770C2 |
| DOSAGE FORMS OF HISTONE DEACETYLASE INHIBITOR IN COMBINATION WITH BENDAMUSTINE AND THEIR APPLICATION | 2011 |
|
RU2609833C2 |
| PHARMACEUTIC COMPOSITION FOR PROLONGED RELEASE OF HYDRALAZINE AND ITS APPLICATION AS AXILLIARY MEDICATION IN CANCER TREATMENT | 2004 |
|
RU2391102C2 |
| DOSAGE FORMS OF RISEDRONATE | 2005 |
|
RU2381791C2 |
| USING 5-AMINOLEVULINIC ACID AND DERIVATIVES THEREOF IN SOLID FORM FOR PHOTODYNAMIC TREATMENT AND DIAGNOSTICS | 2008 |
|
RU2521228C2 |
| MODIFIED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING FEBUXOSTAT | 2011 |
|
RU2602188C2 |
| PHARMACEUTICAL COMPOSITIONS OF ACOTIAMIDE AND PROTON PUMP INHIBITOR | 2019 |
|
RU2820820C2 |
| SYNERGETIC ANALGETIC COMBINATION OF OPIOID ANALGETIC AGENT AND CYCLOOXYGENASE-2 INHIBITOR | 1998 |
|
RU2232600C2 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF INFLAMMATORY INTESTINAL DISEASES (IID) | 2010 |
|
RU2561040C2 |
| MEDICINAL FORMS ON BASIS OF BIPHOSPHONATES | 2005 |
|
RU2359678C2 |
